Search filters

List of works by Krzysztof Simon

A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis.

scientific article published on 17 August 2017

A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.

scientific article published on 11 May 2010

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

scientific article published on July 2011

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).

scientific article

Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis

scientific article published on March 14, 2011

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

scientific article published on 08 June 2020

Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.

scientific article published in August 2007

Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations

scientific article published on August 2010

Case report of African tick-bite fever from Poland.

scientific article published on 18 December 2013

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

scientific article published on 07 February 2020

Chloroquine and hydroxychloroquine for the prevention and therapy of COVID-19: new hopes and old cardiovascular concerns

scientific article published on 14 July 2020

Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies

scientific article published on 17 December 2013

Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study

scientific article published on 10 April 2013

Clinical and epidemiological assessment of hepatitis C virus infection among voluntary blood donors.

scientific article published in August 2002

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

scientific article published on 13 December 2019

DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin.

scientific article

Diagnostic challenges in primary hepatocellular carcinoma: case reports and review of the literature

scientific article

Differences in the courses of meningococcal and pneumococcal cerebrospinal meningitis

scientific article published on 20 January 2020

Distribution of HBV genotypes in Poland

scientific article published on 30 April 2015

Distribution of HCV genotypes in Poland

scientific article published in January 2013

Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study

scientific article published on 03 July 2018

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype

article

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19

scientific article published on 8 March 2021

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

scientific article published on August 2010

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

scientific article

Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.

scientific article published on 26 May 2017

Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study

scientific article published on 28 November 2016

Elevated circulating endothelial cell-derived microparticle levels in patients with liver cirrhosis: a preliminary report

scientific article published on 16 November 2015

Endoscopy in the diagnosis of chronic hepatitis C--diagnosis and therapy depending on the phase of diseases progression and liver regeneration

scientific article published in January 2002

Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure.

scientific article published on 20 May 2016

Epidemic of EHEC (Escherichia coli O104:H4) in Europe in 2011--clinical and therapeutic problems

scientific article published on January 1, 2012

Evaluation of hepatic fibrosis - access to non-invasive methods, national practice/guidelines in Central Europe

scientific article published on 24 March 2016

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

scientific article published on 01 May 2021

Gastrointestinal symptoms as the first, atypical indication of SARS-CoV-2 infection

scientific article published on 03 April 2020

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

scientific article published on 13 January 2022

HIV/AIDS and aging

scientific article published on January 1, 2010

HLA antigens and the antibody response after vaccination to hepatitis B.

scientific article published in January 1988

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B

scientific article published on 04 August 2019

Hepatitis B e antigen levels and response to peginterferon: influence of precore and basal core promoter mutants

scientific article published on 26 December 2012

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

scientific article published in September 2022

Hepatitis C virus load and expression of a unique subset of cellular genes in circulating lymphoid cells differentiate non-responders from responders to pegylated interferon alpha-ribavirin treatment

scientific article

Impact of vaccination against HBV on hepatitis B incidence in Opolskie province in 2007-2011.

scientific article published on January 2015

Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.

scientific article published on September 2017

Interferon and tumor necrosis factor responses of HIV+ patients as markers for monitoring of the AIDS progression

scientific article published in January 1994

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

scientific article published in February 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

scientific article published on 10 November 2020

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders

scientific article published in September 2012

Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up

scientific article published on 27 September 2018

Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline

scientific article published on 20 January 2014

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

scientific article published on 13 June 2020

Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2)

scientific article published on 15 March 2019

Lymphocyte subsets in haematological patients with COVID-19: Multicentre prospective study

scientific article published on 11 November 2020

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

scientific article published on 29 October 2020

Manganese Encephalopathy among Ephedron Abusers.

scientific article published on 26 September 2014

Mild form of Lyell's syndrome as an consequence of inappropriate BCG revaccination--case report

scientific article published on October 2004

Molecular virology and treatment of patients with chronic hepatitis C

scientific article published in January 2005

Neurological complications of SARS-CoV-2 infection in a 66-year-old man

scientific article published on 11 August 2020

Non-interventional study AI463-12 of real-world chronic HBV infection management--baseline characteristics and treatment patterns of Polish patients kohort

Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies

scientific article published on 01 August 2020

Nutrition principles and recommendations in different types of hepatic encephalopathy

scientific article published on 08 February 2016

Occurrence of Legionella sp. in water systems of public facilities in Opole Province in the years 2010-2011

scientific article published on 01 January 2012

Overuse of high stability antibiotics and its consequences in public and environmental health

scientific article

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

article

Peg-interferon improves liver histology in patients with HBeAg-positive chronic hepatitis B: no additional benefit of combination with lamivudine

article

Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patients.

scientific article published on 25 September 2015

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

scientific article

Picolinic acid in patients with chronic hepatitis C infection: a preliminary report

scientific article

Polish Group of Experts of HBV--collective to vaccinations: vaccinations against hepatitis A and B

scientific article published on 01 January 2012

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B.

scientific article published on 11 August 2014

Possibility of persistent replication of HBV in patients with serological evidence of virus elimination

scientific article published in December 2002

Posters

scientific article published on 5 July 2018

Posters

Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries

scientific article published on 15 December 2013

Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.

scientific article

Prevalence and risk factors of HCV infection in Poland

scientific article published in November 2011

Prevalence of HCV genotypes in Poland - the EpiTer study

scientific article published on 28 November 2016

Problem of HIV-infected patients receiving dialysis

scientific article

Rapid decline of viral RNA in chronic hepatitis C patients treated once daily with IDX320: a novel macrocyclic HCV protease inhibitor.

scientific article published on 16 March 2012

Rapid progression of lung inflammatory infiltrates in SARS-CoV-2 infection in a young man

scientific article published on 08 April 2020

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy

scientific article published on 03 March 2019

Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study

scientific article published on 25 July 2019

Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study.

scientific article published on 9 September 2016

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

scientific article

Recommendations for elastography-based imaging of liver.

scientific article

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)

Recommendations for the treatment of hepatitis B in 2017

scientific article published on 10 May 2017

Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015

scientific article published in January 2015

Recommendations for the treatment of hepatitis C in 2017

scientific article published on 18 May 2017

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016

scientific article published on 07 April 2016

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015

scientific article published on 16 November 2015

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

scientific article published on 31 March 2020

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

scientific article published on 01 September 2020

Recurrent meningitis--a review of current literature

scientific article published on January 1, 2013

Results of the treatment of chronic hepatitis B with interferon alfa (wellferon)

scientific article published on January 1, 1991

Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures

scientific article published on 20 January 2012

Searching for the optimal population for hepatitis C virus screening in Poland

scientific article published on 30 April 2020

Serum concentrations of selected adipokines in virus-related liver cirrhosis and hepatocellular carcinoma

scientific article published on 30 September 2020

Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)

scientific article published on 14 January 2020

Severe course of COVID-19 in a middle-aged man without risk factors

scientific article published on 03 April 2020

Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014

scientific article published on 01 January 2014

Successful twice interrupted therapy of HCV infection in patients with cirrhosis with hepatocellular carcinoma before and after liver transplantation

scientific article published on 15 September 2017

Surveillance programmes for early detection of hepatocellular carcinoma

scientific article published on 29 September 2012

Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b

scientific article published on 15 May 2008

The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation

scientific article

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

The expectations for results of clinical trial "IDEAL"

scientific article published in January 2006

The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa

scientific article published in January 2005

The influence of anti-HBc status on the sustained virological response rate in HCV-infected patients treated with pegylated interferon alfa 2 and ribavirin

scientific article published on 28 November 2016

The risk of complications of endoscopic procedures in patients with liver cirrhosis

scientific article published on 25 September 2017

Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.

scientific article published in January 2013

Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection

scientific article published in January 2010

Therapy of hepatitis C: individualized approach to treatment

scientific article published on January 1, 2011

Tissue laser biostimulation promotes post-extraction neoangiogenesis in HIV-infected patients

scientific article

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

scientific article published on 9 April 2021

Treatment of HCV infection in Poland at the beginning of the interferon-free era - the EpiTer-2 study

scientific article published on 6 January 2018

Usefulness of portable chest radiography in initial diagnosis of COVID-19

scientific article published on 15 July 2020

[Acute brucellosis--report of two cases].

scientific article published on January 2006

[Assessment and monitoring of patients with chronic hepatitis C on antiviral therapy--state of the art in 2003]

scientific article published on 01 July 2004

[Clinical picture of Herpesviridae infections among immunocompromised patients: bone marrow and solid organ transplants recipients]

scientific article published on 01 January 2003

[Coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV)]

scientific article published on 01 June 2002

[Diagnosis and therapy of portal hypertension with special reference to endoscopic methods]

scientific article published on 01 January 2006

[Fatty liver disease--mechanism, clinical significance and factors with a special regard to primary hepatotropic viruses]

scientific article published on 01 January 2006

[Hepatitis B virus genotypes and the response to lamivudine therapy]

scientific article published on 01 December 2005

[Natural history of the HIV infection and changes in the central nervous system]

scientific article published on 01 January 2002

[Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]

scientific article published on 01 January 2008

[Porphyria cutanea tarda and HCV infection]

scientific article published on 01 April 2003

[Rational choice of pharmaceutical products]

scientific article published on 01 September 2003

[Rules of management and treatment the patients with recurrent hepatitis C after liver transplantation]

scientific article published on 01 December 2005

[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts]

scientific article published on 01 January 2012

[Therapeutic efficacy of low-dose alpha interferon therapy in liver cirrhosis associated with HBV]

scientific article published on 01 June 1998

[Unsolved problem of current hepatology: the diagnosis and therapy of autoimmune overlap syndrome]

scientific article published on 01 February 2003

[Zinc status in ex-intravenous drug users infected by HIV, without clinical presentation of AIDS]

scientific article published on 01 January 2004

Paulina is supported by:

About Paulina

Help